Share Email Print
cover

Proceedings Paper

Preparation, characterization, and cellular studies of photosensitizer-loaded lipid nanoparticles for photodynamic therapy
Author(s): Fabrice P. Navarro; Denise Bechet; Thomas Delmas; Pierre Couleaud; Céline Frochot; Marc Verhille; Ezatul Kamarulzaman; Régis Vanderesse; Patrick Boisseau; Isabelle Texier; Julien Gravier; Françoise Vinet; Muriel Barberi-Heyob; Anne Claude Couffin
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

PhotoDynamic Therapy (PDT) has been established as a potent and less invasive treatment for different kinds of cancer. Among various attempts to enhance the therapeutics efficacy of PDT, the specific delivery of the PhotoSensitizer (PS) in the tumor is expected to increase its clinical applications, since unwanted accumulation, especially in the skin, impairs the patients' quality of life (prolonged cutaneous photosensitivity). The aim of this study was to engineer Lipid Nanoparticles (LNP) with different sizes and various PS contents, using simple, solvent-free and easily scale up manufacturing processes. Meso-tetra (hydroxyphenyl) chlorin (mTHPC) is one of the most potent photoactive compounds for clinical use and it has been successfully applied in the treatment of various indications, such as the head and neck, prostate and pancreatic cancers. Here, a derivative of mTHPC was efficiently incorporated into the lipid core of LNP, leading to a large range of stable and reproducible mTHPC-loaded LNP with narrow size distribution. The photophysical and photochemical properties of mTHPC-loaded LNP were studied by measuring absorbance and fluorescence spectra, colloidal stability, particle size and zeta potential, as well as singlet oxygen luminescence. The photocytotoxicity of three selected mTHPC-loaded LNP (25 nm, 45 nm and 95 nm of diameter, respectively) was evaluated on MCF-7 cells, in comparison to free mTHPC, under irradiation at 652 nm with a range of light fluence from 1 to 5 J/cm2. All the physico-chemical, photophysical and biological measurements allow us to conclude that LNP is a promising nano-drug delivery system for PDT.

Paper Details

Date Published: 17 February 2011
PDF: 12 pages
Proc. SPIE 7886, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XX, 78860Y (17 February 2011); doi: 10.1117/12.876125
Show Author Affiliations
Fabrice P. Navarro, CEA LETI (France)
Denise Bechet, CRAN, CNRS, Nancy-Univ. (France)
Thomas Delmas, CEA LETI (France)
Pierre Couleaud, LRGP, CNRS, Nancy-Univ. (France)
Céline Frochot, LRGP, CNRS, Nancy-Univ. (France)
GdR, CNRS, PHOTOMED (France)
Marc Verhille, LRGP, CNRS, Nancy-Univ. (France)
Ezatul Kamarulzaman, LCPM, CNRS, Nancy-Univ. (France)
Régis Vanderesse, LCPM, CNRS, Nancy-Univ. (France)
GdR, CNRS, PHOTOMED (France)
Patrick Boisseau, CEA LETI (France)
Isabelle Texier, CEA LETI (France)
Julien Gravier, CEA LETI (France)
Françoise Vinet, CEA LETI (France)
Muriel Barberi-Heyob, CRAN, CNRS, Nancy-Univ. (France)
GdR, CNRS, PHOTOMED (France)
Anne Claude Couffin, CEA LETI (France)


Published in SPIE Proceedings Vol. 7886:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XX
David H. Kessel; Tayyaba Hasan, Editor(s)

© SPIE. Terms of Use
Back to Top